These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 22324898)

  • 41. Complement in age-related macular degeneration: a focus on function.
    Bradley DT; Zipfel PF; Hughes AE
    Eye (Lond); 2011 Jun; 25(6):683-93. PubMed ID: 21394116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toll-Like Receptors and Age-Related Macular Degeneration.
    Mulfaul K; Rhatigan M; Doyle S
    Adv Exp Med Biol; 2018; 1074():19-28. PubMed ID: 29721923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inflammation and the pathogenesis of age-related macular degeneration.
    Augustin AJ; Kirchhof J
    Expert Opin Ther Targets; 2009 Jun; 13(6):641-51. PubMed ID: 19456269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pentraxin 3 recruits complement factor H to protect against oxidative stress-induced complement and inflammasome overactivation.
    Wang L; Cano M; Datta S; Wei H; Ebrahimi KB; Gorashi Y; Garlanda C; Handa JT
    J Pathol; 2016 Dec; 240(4):495-506. PubMed ID: 27659908
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The aged retinal pigment epithelium/choroid: a potential substratum for the pathogenesis of age-related macular degeneration.
    Chen H; Liu B; Lukas TJ; Neufeld AH
    PLoS One; 2008 Jun; 3(6):e2339. PubMed ID: 18523633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Innate Immunity in Age-Related Macular Degeneration.
    Zhang Y; Wong WT
    Adv Exp Med Biol; 2021; 1256():121-141. PubMed ID: 33848000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
    Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
    Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NLRP3 inflammasome: activation and regulation in age-related macular degeneration.
    Gao J; Liu RT; Cao S; Cui JZ; Wang A; To E; Matsubara JA
    Mediators Inflamm; 2015; 2015():690243. PubMed ID: 25698849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunology of age-related macular degeneration.
    Ambati J; Atkinson JP; Gelfand BD
    Nat Rev Immunol; 2013 Jun; 13(6):438-51. PubMed ID: 23702979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
    Richards A; Kavanagh D; Atkinson JP
    Adv Immunol; 2007; 96():141-77. PubMed ID: 17981206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration.
    Bhutto IA; Baba T; Merges C; Juriasinghani V; McLeod DS; Lutty GA
    Br J Ophthalmol; 2011 Sep; 95(9):1323-30. PubMed ID: 21633121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AMD-like retinopathy associated with intravenous iron.
    Song D; Kanu LN; Li Y; Kelly KL; Bhuyan RK; Aleman T; Morgan JI; Dunaief JL
    Exp Eye Res; 2016 Oct; 151():122-33. PubMed ID: 27565570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of Mouse and Human Retinal Pigment Epithelium Gene Expression Profiles: Potential Implications for Age-Related Macular Degeneration.
    Bennis A; Gorgels TG; Ten Brink JB; van der Spek PJ; Bossers K; Heine VM; Bergen AA
    PLoS One; 2015; 10(10):e0141597. PubMed ID: 26517551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular Mechanisms of Complement System Proteins and Matrix Metalloproteinases in the Pathogenesis of Age-Related Macular Degeneration.
    Mansoor N; Wahid F; Azam M; Shah K; den Hollander AI; Qamar R; Ayub H
    Curr Mol Med; 2019; 19(10):705-718. PubMed ID: 31456517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathway activation profiling reveals new insights into age-related macular degeneration and provides avenues for therapeutic interventions.
    Makarev E; Cantor C; Zhavoronkov A; Buzdin A; Aliper A; Csoka AB
    Aging (Albany NY); 2014 Dec; 6(12):1064-75. PubMed ID: 25543336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The case for complement and inflammation in AMD: open questions.
    Karagianni N; Adamis AP
    Adv Exp Med Biol; 2010; 703():1-7. PubMed ID: 20711703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD.
    Datta S; Cano M; Ebrahimi K; Wang L; Handa JT
    Prog Retin Eye Res; 2017 Sep; 60():201-218. PubMed ID: 28336424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estrogen signalling in the pathogenesis of age-related macular degeneration.
    Kaarniranta K; Machalińska A; Veréb Z; Salminen A; Petrovski G; Kauppinen A
    Curr Eye Res; 2015 Feb; 40(2):226-33. PubMed ID: 24911983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduction of endogenous angiogenesis inhibitors in Bruch's membrane of the submacular region in eyes with age-related macular degeneration.
    Bhutto IA; Uno K; Merges C; Zhang L; McLeod DS; Lutty GA
    Arch Ophthalmol; 2008 May; 126(5):670-8. PubMed ID: 18474778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanism of inflammation in age-related macular degeneration.
    Parmeggiani F; Romano MR; Costagliola C; Semeraro F; Incorvaia C; D'Angelo S; Perri P; De Palma P; De Nadai K; Sebastiani A
    Mediators Inflamm; 2012; 2012():546786. PubMed ID: 23209345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.